ARCHIVED: Obituary for Charles Aubrey LeMaistre, M.D.
Charles Aubrey LeMaistre, M.D.
1924-2017
Charles Aubrey ¡°Mickey¡± LeMaistre, M.D., beloved physician, father, trusted friend and husband, passed away in Houston on January 28, 2017, less than two weeks before his 93rd birthday. Mickey was the epitome of a man who cared for others and practiced great discipline in his life.
Mickey LeMaistre¡¯s career began at age 10, as a deckhand spotting fish for tourists in Hogtown...
ARCHIVED: Two migration proteins boost predictive value of pancreatic cancer biomarker
Adding two blood-borne proteins associated with cancer cell migration increases the predictive ability of the current biomarker for pancreatic...
ARCHIVED: Study reveals PGK1 enzyme as therapeutic target for deadliest brain cancer
Discovery of a dual role played by the enzyme phosphoglycerate kinase 1 (PGK1) may indicate a new therapeutic target for glioblastoma, an...
ARCHIVED: Lung cancer cells susceptible to inhibitor treatment via newly discovered pathway
Next-generation cyclin dependent kinase 2/9 (CDK2/9) inhibitors offer a novel way to treat lung cancer with minimal toxic side effects on normal cells, according to a laboratory study by researchers at Â鶹ӳ» MD Anderson Cancer Center. The examined inhibitors were effective in stopping growth of lung cancer cells through induced anaphase catastrophe, a cellular pathway discovered at MD Anderson.
One of these highly...
ARCHIVED: Gut bacteria associated with cancer immunotherapy response in melanoma
Melanoma patients¡¯ response to a major form of immunotherapy is associated with the diversity and makeup of trillions of potential allies...
ARCHIVED: Hormonal maintenance therapy may improve survival in women with chemo-resistant rare ovarian or peritoneum cancer
For women with a rare subtype of epithelial ovarian or peritoneum cancer, known as low-grade serous carcinoma (LGSC), hormone maintenance...
ARCHIVED: MD Anderson receives $19.5 million in CPRIT funding for recruitment and prevention
Â鶹ӳ» MD Anderson Cancer Center this week was awarded $19.5 million from the Cancer Prevention and Research Institute of...
ARCHIVED: More patients with early-stage breast cancer may be able to avoid chemotherapy in the future
Women with early-stage breast cancer who had an intermediate risk recurrence score (RS) from a 21-gene expression assay had similar outcomes...
ARCHIVED: MD Anderson designated first Project ECHO superhub for oncology
Recognizing a critical need to address disparities in cancer care, Â鶹ӳ» MD Anderson Cancer Center has been designated as...
ARCHIVED: Scientists identify aggressive pancreatic cancer cells and their vulnerability
Researchers have identified a gatekeeper protein that prevents pancreatic cancer cells from transitioning into a particularly aggressive cell...
ARCHIVED: Breast cancer patients with dense breast tissue more likely to develop contralateral disease
Breast cancer patients with dense breast tissue have almost a two-fold increased risk of developing disease in the contralateral breast, according...
ARCHIVED: MD Anderson to present Making Cancer History? Seminar in Indian Wells
Â鶹ӳ» MD Anderson Cancer Center returns to Southern California this month with its Making Cancer History? Seminar, 3:30-...
ARCHIVED: Researchers identify ¡®synthetic essentiality¡¯ as novel approach for locating cancer therapy targets
A new method has been found for identifying therapeutic targets in cancers lacking specific key tumor suppressor genes. The process, which...
ARCHIVED: MD Anderson supports World Cancer Day with allies around the globe
In honor of World Cancer Day on Feb. 4, Â鶹ӳ» MD Anderson Cancer Center calls for health care providers, organizations,...